Sinovac Biotech Ltd (SVA) Diversifiers

Equity · Currency in USD · Last updated Jun 4, 2026

Sinovac Biotech Ltd. focuses on the research, development, manufacture, and commercialization of vaccines against human infectious diseases, offering products targeting hepatitis A and B, influenza strains, coronavirus, varicella, mumps, pneumococcal infections, and hand, foot, and mouth disease, with ongoing development of polio and rubella vaccines. The company also collaborates with other biotech firms to develop combination vaccines and advance clinical trials for vaccines such as CoronaVac against COVID-19.

Looking to balance out your exposure to SVA? The ETFs below have the lowest correlation with SVA — they tend to move on their own, which can help reduce risk when SVA drops. The stock ideas table highlights individual companies that behave independently from SVA.

No Diversifiers Found for SVA

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements SVA

Add SVA to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with SVA